Ofatumumab With or Without Bendamustine for Patients With Mantle Cell Lymphoma Ineligible for Autologous Stem Cell Transplant.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2016
At a glance
- Drugs Ofatumumab (Primary) ; Bendamustine
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 25 Apr 2016 Planned End Date changed from 1 Sep 2016 to 1 Sep 2017.
- 25 Apr 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.
- 25 Apr 2016 Status changed from recruiting to active, no longer recruiting.